Zachary T. Giaccone

Abstract B32: Mutant KRAS downregulates LIFR to enhance glycolysis in pancreatic cancer

Brian M. Wolpin, Suhu Liu, Helen I. Gandler, 2019 .

The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer

Zachary T. Giaccone, D. Frank, F. Gounari, 2017, Cancer Immunology, Immunotherapy.

IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment.

Zachary T. Giaccone, A. Raj, Qi Long, 2018, Cancer research.

Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent.

Traci M. Blonquist, Darwin Q. Ye, Zachary T. Giaccone, 2016, Blood.

Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer

Helen I. Gandler, Darwin Q. Ye, Zachary T. Giaccone, 2021, Molecular Cancer Research.

Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

Zachary T. Giaccone, S. Tyekucheva, Catherine J. Wu, 2020, American journal of hematology.

IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment.

Zachary T. Giaccone, A. Raj, Qi Long, 2018, Cancer Research.